PAEDIATRIC
PAEDIATRIC
SKIN & SOFT TISSUE INFECTIONS
Staphylococcus aureus
Preferred
Mild
*Cloxacillin 50-100mg/kg/day PO in 4 divided doses (max. 1g/day) for 5-7 days
Severe
Cloxacillin 200mg/kg/day IV in 4 divided doses (max. 12g/day) for 5-7 days
CA-MRSA
Clindamycin 30-40mg/kg/day PO in 3-4 divided doses (max. 1.8g/day) for 5-7 days
OR
Trimethoprim/sulfamethoxazole 8-12mg/kg/day (TMP dose) PO in 2 divided doses (max. 320mg/day) for 5-7 days
Alternative
Mild
Cephalexin 25-50mg/kg/day PO in 2 divided doses (max. 2g/day) for 5-7 days
Comments
Incision & drainage (I&D) is the MAINSTAY of therapy. If needle aspiration is inadequate, can send pus obtained during I&D for C&S.
Use parenteral route for severe infections. Consider CA-MRSA if poorly resolving, based on local epidemiology (still generally uncommon).
*Doses recommended are for children weighing less than 25kg. For children weighing more than 25kg, use adult dosage (500mg PO q6h).
Common organisms:
Staphylococcus aureus
Streptococcus pyogenes
Preferred
Mild
*Cloxacillin 50-100mg/kg/day PO in 4 divided doses (max. 1g/day) for 5-7 days
Severe
Cloxacillin 200mg/kg/day IV in 4 divided doses (max. 12g/day) for 5-7 days
Alternative
Cephalexin 25-50mg/kg/day PO in 2 divided doses (max. 2g/day) for 5-7 days
Comments
Administer using parenteral route for extensive lesions.
Total treatment until 3 days after acute inflammation disappears.
*Doses recommended are for children weighing less than 25kg. For children weighing more than 25kg, use adult dosage (500mg PO q6h).
Mycobacterium leprae
Preferred
˂ 10 years old or < 40kg
Rifampicin 10mg/kg PO (max. 600mg/day) once a month
PLUS
Dapsone 2mg/kg PO q24h (max. 100mg/day)
PLUS
Clofazimine 100mg PO once a month, 50mg twice weekly
10-14 years old
Rifampicin 450mg PO (max. 600mg/day) once a month
PLUS
Dapsone 50mg PO q24h (max. 100mg/day)
PLUS
Clofazimine 150mg PO once a month & 50mg alternate day
Alternative
--
Comments
Duration:
Paucibacillary: 6 months
Surveillance 5 years
Multibacillary: 12 months
Surveillance 15 years
Common organisms:
Staphylococcus aureus
Streptococcus pyogenes
Preferred
Localised:
Topical 2% fusidic acid 2-3 times daily for 7 days (outpatient)
Generalised:
*Cloxacillin 50-100mg/kg/day PO in 4 divided doses (max. 1g/day) for 5-7 days
Alternative
Localised:
Topical 2% Mupirocin cream 2-3 times daily for 7 days
Generalised:
Cephalexin 25-50mg/kg/day PO in 2 divided doses (max. 2g/day) for 5-7 days
Comments
*Doses recommended are for children weighing less than 25kg. For children weighing more than 25kg, use adult dosage (500mg PO q6h).
Streptococcus spp.:
Group A Streptococcus (GABHS),
Other streptococcus
Staphylococcal:
Staphylococcal aureus (MSSA & CA-MRSA)
Other pathogens to consider:
Clostridia sp.
Polymicrobial
5.1 Streptococcal Necrotising Fasciitis
Preferred
Benzylpenicillin 200,000-300,000units/kg/day IV in 4-6 divided doses (max. 24 million units/day)
PLUS
Clindamycin 10mg/kg IV q6h (max: 4.8g/day)
Alternative
--
Comments
50% of patients have associated streptococcal toxic shock syndrome (STSS).
Prompt and aggressive surgical debridement of the deep-seated infection is the mainstay of therapy.
Tissues should be sent for Gram stain and culture to determine etiology.
Combination therapy is needed with clindamycin to block toxin production whether or not patient manifests toxic shock syndrome.
IVIG can be used as an adjunct in Group A streptococcal infection, typically at 1g/kg on Day 1, followed by 0.5g/kg on 1-2 subsequent days.
Duration: at least 2 weeks if no foci is found (no deep-seated involvement plus no involvement of heart, bone, joint etc.)
5.2 Staphylococcal Necrotising Fasciitis
Preferred
Cloxacillin 200mg/kg/day IV in 4-6 divided doses (max. 1g/day)
PLUS
Clindamycin 10mg/kg IV q6h (max: 4.8g/day)
Alternative
If CA-MRSA is suspected:
Vancomycin 60mg/kg/day IV in 3-4 divided doses (max. 2g/day)
Comments
Prompt and aggressive surgical debridement of the deep-seated infection is the mainstay of therapy.
Tissues should be sent for Gram stain and culture to determine etiology.
Combination therapy is needed with clindamycin to block toxin production whether or not patient manifests toxic shock syndrome.
Vancomycin is NOT RECOMMENDED for the treatment of serious MSSA infections because outcomes are INFERIOR compared with cases in which anti-staphylococcus β-lactam (cloxacillin) is used AND to minimise the emergence of vancomycin resistance.
Duration: at least 2 weeks if no foci is found (no deep-seated involvement plus no involvement of heart, bone, joint etc.)
Staphylococcus aureus
Preferred
Cloxacillin 200mg/kg/day IV in 4-6 divided doses (max. 12g/day)
Step down
Cloxacillin 25-50mg/kg/day PO in 4 divided doses (max. 1g/day)
Total treatment duration: 7-10 days
Alternative
--
Comments
Switch to oral therapy when the patient shows clinical improvement and negative blood culture results.
Doses recommended are for children weighing less than 25kg. For children weighing more than 25kg, use adult dosage.
7.1 Cat Bites
Common organisms:
Pasteurella multocida
Staphylococcus spp.
Streptococcus spp.
Neisseria
Moraxella
Preferred
Amoxicillin/clavulanate
Amoxycillin component:
Suspension (Formulation 14:1)
Amoxicillin / Clavulanate 80-90mg/kg/day PO in 2 divided doses (max. amoxicillin 2g/day) for 5-7 days
Suspension (Formulation 7:1)
Amoxicillin / Clavulanate 40-45mg/kg/day PO in 2 divided doses (max. amoxicillin 2g/day) for 5-7 days
Alternative
Amoxicillin/clavulanate 25mg/kg/dose (amoxicillin component) IV q8h (max. amoxicillin 3g/day)
Comments
Consider rabies prophylaxis according to local epidemiology.
Other animal bites: to discuss with ID Physician.
7.2 Dog Bites
Common organisms:
Pasteurella canis
Staphylococcus sp
Streptococcus sp
Fusobacterium
Preferred
Amoxicillin/clavulanate
Amoxycillin component:
Suspension (Formulation 14:1)
Amoxicillin / Clavulanate 80-90mg/kg/day PO in 2 divided doses (max. amoxicillin 2g/day) for 5-7 days
Suspension (Formulation 7:1)
Amoxicillin / Clavulanate 40-45mg/kg/day PO in 2 divided doses (max. amoxicillin 2g/day) for 5-7 days
Alternative
Amoxicillin/clavulanate 25mg/kg/dose (amoxicillin component) IV q8h (max. amoxicillin 3g/day)
OR
Clindamycin 20-40mg/kg/day IV in 3 divided doses (max. 4.8g/day)
PLUS
Co-trimoxazole 8-10mg (TMP)/kg/day IV in 2 divided doses (max. 320mg TMP/day)
Comments
Consider rabies prophylaxis according to local epidemiology.
Other animal bites, to discuss with ID Physician.
Preferred
Infant < 2 months
Sulphur 6% in petroleum in ointment base for 3 days
Children < 2 years
Two applications of Permethrin 5% for 8-12 hours at one week apart
Children < 12 years
Two applications of permethrin 5% for 8-12hours at one week apart
Nodular scabies
Children < 2 years
Crotamiton cream TDS for 5-7 days
Children < 12 years
Crotamiton cream TDS for 7-14 days
Alternative
Children < 2 years
Sulphur 6% in petroleum in ointment base for 3 days
Children < 12 years
Benzyl Benzoate 12.5% Whole body neck and below for 3 consecutive days
Comments
Treat whole body including the face (avoid eyes and mouth).
Treat all family members/close contacts simultaneously.
Refer to Ministry of Health Guideline for Management of Scabies in Adults and Children (2015) for cautions and topical application method.
Trichophyton spp., Microsporum spp.
Preferred
Griseofulvin 10-20mg/kg/day PO daily (max. 750mg/day) for at least 6 weeks until clinically clear
Alternative
Terbinafine 4-6mg/kg/day PO daily (max. 250mg/day) for 4 weeks or longer depend on pathogen
10-20kg: 62.5mg daily
20-40kg: 125mg daily
> 40kg: 250mg daily
OR
Itraconazole 3-5mg/kg/day PO daily (max. 200mg/day) for 2-6 weeks
OR
Fluconazole 5-6mg/kg/day PO (max. 300mg/day) for 3-6 weeks
Comments
Griseofulvin:
First line treatment for Microsporum sp
Take with fatty food. Monitor liver function if treatment duration > 8 weeks
Adjunctive selenium or ketoconazole shampoo can reduce transmissibility.
References:
Guidelines For the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America (IDSA): Clin Infect Dis 2014;59:E10
Malaysian Clinical Practice Guideline on Management of Leprosy 2014
The Sanford Guide to Antimicrobial Therapy 2022
American Academy of Paediatrics Commitee on Infectious Diseases. Red Book: Report Of the Committee on Infectious Diseases (2021-2024)
Guidelines For the Diagnosis, Treatment and Prevention of Leprosy ISBN: 978 92 9022 638 3. World Health Organization 2018
Guideline For Management Of Scabies In Adults And Children KKM 2015
The Royal Children's Hospital Melbourne Clinical Practice Guideline Cellulitis and other bacterial skin infections Last updated March 2020
The Royal Children's Hospital Melbourne Clinical Practice Guideline Animal and Human Bites Last updated March 2023
British National Formulary for Children 2022-2023
Micromedex Pediatric Reference version 5.5.0 (485)